✦ LIBER ✦

Processing-dependent and -independent pathways for recognition of iodinated contrast media by specific human T cells

✍ Scribed by M. Keller; M. Lerch; M. Britschgi; V. Tâche; B. O. Gerber; M. Lüthi; P. Lochmatter; G. Kanny; A. J. Bircher; C. Christiansen; W. J. Pichler

Book ID: 108688649
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 358 KB
Volume: 40
Category: Article
ISSN: 0954-7894
DOI: 10.1111/j.1365-2222.2009.03425.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of apoptosis by the novel reti

Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways

✍ Adachi, Hiroshi; Adams, Anthony; Hughes, Francis M; Zhang, Jiandi; Cidlowski, Jo 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 339 KB

Involvement of both caspase-dependent an

Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells

✍ Ingegerd Eggen Furre; Michael T. N. Møller; Susan Shahzidi; Jahn M. Nesland; Qia 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 603 KB

Modulation of surface T11 molecules indu

Modulation of surface T11 molecules induced by monoclonal antibodies: analysis of the functional relationship between antigen-dependent and antigen-independent pathways of human T cell activation

✍ Alessandro Moretta; Daniel Olive; Alessandro Poggi; Giuseppe Pantaleo; Claude Ma 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 612 KB

Anti-CD3-based bispecific antibody desig

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms

✍ Brian K. Link; Sheri A. Kostelny; Michael S. Cole; William P. Fusselman; J. Yun 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB 👁 2 views

## Anti -CD3 ؋ anti-B-cell antigen bispecific monoclonal antibodies (bsAbs) can redirect T-cell-mediated lysis toward malignant B cells. Clinical trials with CD3-based bsAbs have shown toxicity in patients which is likely related to nonspecific T-cell activation and targeting. Our current studies